Showing 1 - 2 results of 2 for search 'Hegewisch-Becker, S', query time: 0.03s
Refine Results
-
1
NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. by Gnjatic, S, Cao, Y, Reichelt, U, Yekebas, E, Nölker, C, Marx, A, Erbersdobler, A, Nishikawa, H, Hildebrandt, Y, Bartels, K, Horn, C, Stahl, T, Gout, I, Filonenko, V, Ling, K, Cerundolo, V, Luetkens, T, Ritter, G, Friedrichs, K, Leuwer, R, Hegewisch-Becker, S, Izbicki, JR, Bokemeyer, C, Old, L, Atanackovic, D
Published 2010Journal article -
2
Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer by Joseph Tintelnot, Inka Ristow, Markus Sauer, Donjete Simnica, Christoph Schultheiß, Rebekka Scholz, Eray Goekkurt, Eray Goekkurt, Lisa von Wenserski, Edith Willscher, Lisa Paschold, Sylvie Lorenzen, Jorge Riera-Knorrenschild, Reinhard Depenbusch, Thomas J. Ettrich, Steffen Dörfel, Salah-Eddin Al-Batran, Meinolf Karthaus, Uwe Pelzer, Axel Hinke, Marcus Bauer, Chiara Massa, Barbara Seliger, Claudia Wickenhauser, Carsten Bokemeyer, Susanna Hegewisch-Becker, Mascha Binder, Alexander Stein, Alexander Stein
Published 2022-12-01
Article